GLOBAL INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2018-2026

GLOBAL INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2018-2026

  • January 2018 •
  • 135 pages •
  • Report ID: 5304126
KEY FINDINGS
A global rise in infertility and increasing awareness about its effective treatments, combined with the emergence of medical tourism in fertility treatments are propelling the global infertility testing and treatment market. By the end of the forecast period of 2018 – 2026, the market is predicted to evolve at 6.39% CAGR.

MARKET INSIGHTS
The global infertility testing and treatment market is segmented on the basis of male infertility, female infertility and end-users. Both the male and female infertility markets are further sub-segmented into testing and treatment.

Increasing number of couples are opting for IVF techniques, and as a result, the female infertility treatment segment is dominating the market. The end-users for this market are sub-segmented into hospitals and research laboratories, fertility and surgical centers, and cryobanks.

REGIONAL INSIGHTS
Asia-Pacific, Europe, North America and rest of the world are the markets focused for the global infertility testing and treatment market. The European market is expected to capture the highest market share by the end of the estimated period.

The region has a presence of a number of IVF clinics that provide treatments at reasonable costs. The APAC market is also forecasted to exhibit a significant growth over the forecast period, driven by a low birth rate and favourable government initiatives in countries like Taiwan, South Korea, Singapore and Japan.

COMPETITIVE INSIGHTS
Major companies dealing in the infertility testing and treatment market include Endo Pharmaceuticals, Andrology Solutions, Progyny, Genea, Ferring Pharmaceuticals, Halotech DNA, Merck, Irvine Scientific, Origio, Vitrolife Ab, Ovascience, Thermo Fisher Scientific Inc, Quest Diagnostic, The Cooper Companies, Inc, Esco Micro Pte. Ltd, Alere, Elucigene, Celmatrix, Claritas Genomics, Veritas Genetics, Roche, Agilent, LabCorp, Integrated Genetics, Centogene, Phosphorus Diagnostics, Natera Inc, and Illumina Inc.
Country=World Date=201801 Publisher=InkwoodResearch Price=3000